Skip to main content

Table 1 Preoperative characteristics of the study cohort, according to the anesthetic agent used in the donor

From: Sevoflurane preconditioning in living liver donation is associated with better initial graft function after pediatric transplantation: a retrospective study

 

Sevoflurane (n = 69)

Propofol and sevoflurane (n = 29)

Propofol (n = 85)

P value

Donor

 Age (years)

34.3 [29.4–39.0]

33.0 [30.2–36.8]

33.8 [27.7–36.4]

.19

 Sex

   

.94

  Female

31 (44.9)

14 (48.3)

40 (47.1)

  Male

38 (55.1)

15 (51.7)

45 (52.9)

Recipient

 Age (years)

1.3 [0.8–2.4]

2.3 [0.9–4.3]

1.5 [0.9–2.7]

.13

 Sex

   

.94

  Female

40 (58.0)

16 (55.2)

47 (55.3)

  Male

29 (42.0)

13 (44.8)

38 (44.7)

 Weight (kg)

9.4 [7.7–12.4]

12.0 [8.7–15.9]

9.1 [7.4–14.0]

.15

 Liver pathology

   

.10

  Biliary atresia

51 (73.9)

16 (55.2)

51 (60.0)

  Other

18 (26.1)

13 (44.8)

18 (40.0)

 Cirrhosis

59 (85.5)

26 (89.7)

72 (84.7)

.80

 ASAT (U/L)

167 [92–226]

171 [87–249]

144 [82–229]

.97

 ALAT (U/L)

82 [47–124]

119 [38–148]

87 [49–128]

.61

 Bilirubin (mg/dL)

16.1 [2.7–21.5]

13.5 [2.9–22.4]

14.2 [2.9–19.7]

.76

 INR

1.28 [1.11–1.67]

1.19 [1.03–1.57]

1.31 [1.08–1.58]

.38

 Urea (mg/dL)

15 [11–19]

17 [13–26]

17 [14–22]

.14

 Creatinin (mg/dL)

0.24 [0.19–0.31]

0.32 [0.19–0.39]

0.24 [0.19–0.34]

.16

 Albumin (g/L)

33 [29–38]

34 [31–41]

32 [28–37]

.27

 NLR

0.9 [0.7–1.6]

1.1 [0.6–1.4]

1.1 [0.6–1.7]

.51

  1. Data are presented as median [IQR] or numbers (%). Comparisons between groups (sevoflurane, propofol + sevoflurane, and propofol) with a Kruskal-Wallis test (continuous data) or a chi-square (categorical data)
  2. Abbreviations: ASAT Aspartate aminotransferase, ALAT Alanine aminotransferase, NLR Neutrophil/lymphocyte ratio